by Manoranjan Das | Jan 26, 2026 | By Manoranjan Das
In the past, pharmaceutical companies have invested heavily in Next Best Action (NBA) initiatives—rule engines, propensity models, dashboards, and AI-driven recommendations to improve field force effectiveness. Yet the gap persists. Field teams still struggle with...
by Manoranjan Das | Aug 28, 2025 | By Manoranjan Das, Commercial Planning
Why Targeting and Segmentation as a service Bringing a drug to market is never simple—especially in today’s fast-evolving healthcare landscape. For pharmaceutical and biotech companies, one of the toughest hurdles is reaching the right audience—whether that’s...
by Manoranjan Das | May 26, 2025 | By Manoranjan Das
Commercialising a drug is never easy—especially for small to medium-sized pharmaceutical and biotech companies. One of the biggest hurdles? Measuring and optimising field force effectiveness (SFE). While many companies invest in CRM systems to track field activities,...
by Manoranjan Das | Apr 22, 2025 | Santhi Kumar, SnapLogic
Introduction Generative AI (GenAI) is no longer just a tech trend—it’s become a powerful tool woven into our everyday lives. From helping us make quick decisions to solving complex business problems, GenAI is reshaping the way we work and innovate. Its potential is...
